Get the app!
Back to Trades

Martin Samuel Bates

InsiderCIK 0001709024

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
2
Buy transactions
0
Sell transactions
0
Companies
1
Active
2026

Martin Samuel Bates has filed 2 SEC reports (2026), all concentrated in Celldex Therapeutics, Inc. (CLDX), totaling $3.3M in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

2 loaded
Jun 29CLDX
Celldex Therapeutics, Inc.
Martin Samuel BatesInsiderAward$3.2M
Jan 6CLDX
Celldex Therapeutics, Inc.
Martin Samuel BatesInsiderExercise$100.0K

2 filings